Gerald B. W. Wertheim, MD, PhD

faculty photo
Associate Professor of Clinical Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine

Contact information
Department of Pathology and Laboratory Medicine
Children's Hospital of Philadelphia
5199B Main Building
5th Floor
3401 Civic Center Boulevard
Philadelphia, PA 19104
Office: 267-970-5918
Fax: 215-590-1736
Education:
BS (Chemistry)
Yale University, New Haven CT, 1994.
PhD (Cancer Biology)
University of Pennsylvania School of Medicine, 2004.
MD (Medicine)
University of Pennsylvania School of Medicine, 2005.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Lytle A, Pillai V, Wertheim GW, Paessler M, Croy C and Rheingold S: Blinatumomab Induces Bone Marrow Lymphoid Infiltrates That Correlate with Response in B-ALL. United States and Canadian Academy of Pathology 2021 Baltimore, Maryland March 2021.

Wei J, Faude S, Xu X, Wertheim G, Paessler M, Bhoj V, Pillai V: Morphological and Immunophenotypic Characterization of CAR T Cells. United States and Canadian Academy of Pathology 2021 Baltimore, Maryland March 2021.

Kadauke S, Myers RM, Li Y, Aplenc R, Baniewicz D, Barrett DM, Barz Leahy A, Callahan C, Dolan JG, Fitzgerald JC, Gladney W, Lacey SF, Liu H, Maude SL, McGuire R, Motley LS, Teachey DT, Wertheim GB, Wray L, DiNofia AM, Grupp SA: Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial. Journal of Clinical Oncology January 2021 Notes: Online ahead of print.

Zhao X, Kotch C, Fox E, Surrey LF, Wertheim GB, Baloch ZW, Lin F, Pillai V, Luo M, Kreiger PA, Pogoriler JE, Linn RL, Russo PA, Santi M, Resnick AC, Storm PB, Hunger SP, Bauer AJ and Li MM: NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome. JCO Precision Oncology 5: 204-214, January 2021.

Margolskee E, Wertheim GBW, Harvey RC: Pathology and Molecular Diagnosis of Leukemias and Lymphomas. Pizzo and Poplack's Pediatric Oncology 8th Edition Page: 117-128, 2021.

Kelemen K, Saft L, Craig FE, Orazi A, Nakashima M, Wertheim GB, George TI, Horny HP, King RL, Quintanilla-Martinez L, Wang SA, Rimsza LM, Reichard KK: Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders. American journal of clinical pathology December 2020 Notes: Online ahead of print.

Jung HS, Lin F, Wolpaw A, Reilly AF, Margolskee E, Luo M, Wertheim GB, Li MM: A Novel KMT2A-ARHGEF12 Fusion Gene Identified in a High-Grade B-cell Lymphoma. Cancer Genetics Page: 41-43, August 2020 Notes: Online ahead of print.

Hurtz C, Wertheim GB, Loftus JP, Blumenthal D, Lehman A, Li Y, Bagashev A, Manning B, Cummins KD, Burkhardt JK, Perl AE, Carroll M, Tasian SK: Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL. The Journal of Clinical Investigation 130(7): 3637-3653, July 2020.

Rentas S, Pillai V, Wertheim GB, Akgumus GT, Nichols KE, Deardorff MA, Conlin LK, Li MM, Olson TS, Luo M : Evolution of Histomorphologic, Cytogenetic, and Genetic Abnormalities in an Untreated Patient With MIRAGE Syndrome. Cancer Genetics 245: 42-48, July 2020.

Cai Z, Aguilera F, Ramdas B, Daulatabad SV, Srivastava R, Kotzin JJ, Carroll M, Wertheim G, Williams A, Janga SC, Zhang C, Henao-Mejia J, Kapur R.: Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic Cells. Cell Reports 31(12): 107816, June 2020.

back to top
Last updated: 03/18/2021
The Trustees of the University of Pennsylvania